EUVIMEDEUVIMED entdecken
Crossref

Exploring the mechanism of action of Qufengzhitong pills in treating rheumatoid arthritis via the PI3K/AKT, NF-κB, and MAPK pathways

Jie Li, Rongxue Li, Yule Wang, Marwan M A Rashed, Dejun Qi, Yuanjie He, Chenghui He, Yanxu Chang, Sihui Nian, Hong Duan, Henggui Hu, Kefeng Zhai

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgag067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Jie Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Wannan Medical University, Wuhu, Anhui 241002, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Drugs, Chinese Herbal, Proto-Oncogene Proteins c-akt, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To elucidate the therapeutic mechanism of Qufengzhitong Pills (QFZTP) in the treatment of rheumatoid arthritis (RA).

Methods

Blood-absorbed active components of QFZTP and its potential therapeutic targets for RA were screened via liquid chromatography–tandem mass spectrometry (LC-MS/MS) and network pharmacology. Core targets were analyzed using protein–protein interaction networks, with key pathways identified via Gene Ontology/Kyoto Encyclopedia of Genes and Genomes enrichment. Molecular docking was performed for major components and core targets. An IL-1β-induced MH7A cell–based RA model was established; CCK-8, ELISA (IL-6/TNF-α), wound-healing/Transwell, flow cytometry, EdU, and western blot (PI3K/AKT/NF-κB/MAPK pathways) were used to assess cell viability, cytokines, migration, apoptosis, proliferation, and protein expression. Key findings LC-MS/MS identified 92 active components in rat serum, and network pharmacology identified 369 potential QFZTP targets for RA, enriched mainly in TNF signaling, PI3K/AKT, MAPK, and apoptosis pathways. Core components (crocetin, epigallocatechin, bergapten) showed stable binding (<−5.0 kcal/mol) to AKT1, EGFR, and PI3K, occupying similar active pockets as native inhibitors. In vitro, QFZTP-containing serum significantly reduced IL-1β-induced MH7A cell viability; inhibited IL-6/TNF-α secretion (comparable to native QFZTP solution); attenuated migration/proliferation; induced apoptosis; downregulated EGFR, p-PI3K, p-AKT, p-p38, p-NF-κB, and Bcl-2; and up-regulated Bax.

Conclusion

QFZTP synergistically regulates the PI3K/AKT, NF-κB, and MAPK pathways to inhibit synovial cell proliferation and migration, induce apoptosis, and attenuate inflammation. This study provides a robust theoretical and experimental basis for its clinical application in RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidDrugs, Chinese HerbalProto-Oncogene Proteins c-aktNF-kappa BAnimalsRatsPhosphatidylinositol 3-KinasesApoptosisMolecular Docking SimulationCell LineCell ProliferationSignal TransductionTandem Mass SpectrometryNetwork PharmacologyHumansMAP Kinase Signaling SystemCell MovementCell SurvivalRats, Sprague-Dawley

Stichwörter der Autor:innen

PI3K/AKT signaling pathwayQufengzhitong pills (QFZTP)apoptosisrheumatoid arthritis (RA)

Substanzen

Drugs, Chinese HerbalProto-Oncogene Proteins c-aktNF-kappa BPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Pharmacy, Wannan Medical University, Wuhu, Anhui 241002, China.
  • School of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou, Anhui 234000, China.
  • Xinjiang Institute of Materia Medica, Key Laboratory of Xinjiang Uygur Medicine, Urumqi, Xinjiang Uygur Autonomous Region 830010, China.
  • State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, Tianjin Municipality 301617, China.
  • General Clinical Research Center, Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, Anhui Province 234000, China.

Zitieren

APA

Li, J., Li, R., Wang, Y., Rashed, M. M. A., Qi, D., He, Y., He, C., Chang, Y., Nian, S., Duan, H., Hu, H., & Zhai, K. (2026). Exploring the mechanism of action of Qufengzhitong pills in treating rheumatoid arthritis via the PI3K/AKT, NF-κB, and MAPK pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag067

Vancouver

Li J, Li R, Wang Y, Rashed MMA, Qi D, He Y, et al. Exploring the mechanism of action of Qufengzhitong pills in treating rheumatoid arthritis via the PI3K/AKT, NF-κB, and MAPK pathways. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag067

BibTeX
@article{Li2026,
  author = {Li, Jie and Li, Rongxue and Wang, Yule and Rashed, Marwan M A and Qi, Dejun and He, Yuanjie and He, Chenghui and Chang, Yanxu and Nian, Sihui and Duan, Hong and Hu, Henggui and Zhai, Kefeng},
  title = {Exploring the mechanism of action of Qufengzhitong pills in treating rheumatoid arthritis via the PI3K/AKT, NF-κB, and MAPK pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgag067}
}
Kostenlos starten →